Results 1 to 10 of about 5,857,342 (337)

Primary PCI versus pharmacoinvasive strategy for ST elevation myocardial infarction

International Journal of Cardiology: Heart & Vasculature, 2018
Background: The rationale for pharmacoinvasive strategy is that many patients have a persistent reduction in flow in the infarct-related artery.
Ayman M. Helal, Sameh M. Shaheen, Walid A. Elhammady, Mohamed I. Ahmed, Ahmed S. Abdel-Hakim, Lamyaa E. Allam   +5 more
doaj   +4 more sources

Primary PCI and Mental Health: A 12-Month Follow-Up Study [PDF]

Healthcare (Switzerland), 2023
The research article highlights the significance of acute myocardial infarction (AMI) and its impact on depression and anxiety among patients’ post-primary percutaneous coronary interventions (PCI). The study aims to determine the frequency of depression
Veronica Gheorman, Adrian Mită, Mircea-Cătălin Forțofoiu   +2 more
exaly   +3 more sources

Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction [PDF]

New England Journal of Medicine, 2013
BACKGROUNDIt is not known whether prehospital fibrinolysis, coupled with timely coronary angiography, provides a clinical outcome similar to that with primary percutaneous coronary intervention (PCI) early after acute ST-segment elevation myocardial ...
Thierry Danays, YVES LAMBERT, Miodrag Ostojic   +2 more
exaly   +3 more sources

Redefining successful primary PCI [PDF]

European Heart Journal - Cardiovascular Imaging, 2018
No abstract available.
McCartney, Peter J., Berry, Colin
openaire   +4 more sources

Large intracoronary thrombus and its management during primary PCI

Indian Heart Journal, 2020
Large intracoronary thrombus has been reported in significant number of patients with STEMI. Primary PCI is the current standard of care in patients of STEMI.
Vinod Kumar, A. Sharma, Tarun Kumar, R. Nath   +3 more
exaly   +2 more sources

Bivalirudin started during emergency transport for primary PCI. [PDF]

New England Journal of Medicine, 2013
BACKGROUND: Bivalirudin, as compared with heparin and glycoprotein IIb/IIIa inhibitors, has been shown to reduce rates of bleeding and death in patients undergoing primary percutaneous coronary intervention (PCI).
Berg, J. van den, Bernstein, D., Clayton, T., Clemmensen, P., Coste, P., Deliargyris, E.N., Eggink, G.J., et al., Goldstein, P., Grunsven, P. van, Hamm, C.W., Hamon, M., Hof, A. van't, Huber, K., Lapostolle, F., Nef, H., Nibbe, L., Orto, M. Campo dell', Pocock, S., Prats, J., Schuette, D., Soulat, L., Steg, P.G., Steinmetz, J., Verheugt, F.W.A., Zeymer, U.   +25 more
core   +2 more sources

A randomised trial of selective intracoronary hypothermia during primary PCI. [PDF]

EuroIntervention
BACKGROUND While experimental data suggest that selective intracoronary hypothermia decreases infarct size, studies in patients with ST-elevation myocardial infarction (STEMI) are lacking.
El Farissi M, Pijls NHJ, Good R, Engström T, Keeble TR, Beleslin B, De Bruyne B, Fröbert O, Erlinge D, Teeuwen K, Eerdekens R, Demandt JPA, Mangion K, Lonborg J, Setz-Pels W, Karamasis G, Wijnbergen I, Vlaar PJ, de Vos A, Brueren GR, Oldroyd K, Berry C, Tonino PAL, Van't Veer M, Otterspoor LC.   +24 more
europepmc   +2 more sources

Anticoagulants and Primary PCI

, 2018
Percutaneous coronary interventions (PCI) mandate usage of anticoagulants to facilitate a successful and safe procedure. This chapter reviews commonly used anticoagulant regimens used for PCI with tailored guidance for the acute setting, in particular primary PCI for ST-elevation myocardial infarction (STEMI).
F. Jafary
openaire   +2 more sources

State of the Art of Primary PCI: Present and Future. [PDF]

J Clin Med
Primary percutaneous coronary intervention (PCI) has revolutionized the management of ST-elevation myocardial infarction (STEMI), markedly improving patient outcomes. Despite technological advancements, pharmacological innovations, and refined interventional techniques, STEMI prognosis remains burdened by a persistent incidence of cardiac death and ...
Mignatti A, Echarte-Morales J, Sturla M, Latib A.   +3 more
europepmc   +3 more sources

Association between Systemic Immune-Inflammation Index (SII) and New-Onset In-Hospital Heart Failure in Patients with STEMI after Primary PCI [PDF]

Reviews in Cardiovascular Medicine
Background: The systemic immune-inflammation index (SII) is a proven, reliable inflammatory marker of the atherosclerotic process.
Huibo Wang, Ying Yang, Ping Zeng, Rihong Huang, Xinyong Cai, Liang Shao, Fuyuan Liu, Yuhua Lei, Dongsheng Li, Zhixing Fan, Jun Yang, Jing Zhang, Jian Yang   +12 more
doaj   +2 more sources